Lumen HomepageTechnologyPipelinePress

Practical application of nitric oxide technology to the treatment of vascular diseases

Lumen Therapeutics is a privately held, development stage biopharmaceutical company focused on proprietary drugs based on oligo-L-arginine.

The company's lead product has completed a Phase I/IIa clinical trial for the prevention of vein graft failure after bypass graft surgery. Several additional molecules are in preclinical development. read more...

Lumen Therapeutics, LLC     325 Sharon Park Drive, Suite 753, Menlo Park, CA 94025      Phone: (650) 450-4439

© 2005-2010 Lumen Therapeutics   |   All rights reserved.   |